BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18066052)

  • 1. Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation.
    Metzger E; Yin N; Wissmann M; Kunowska N; Fischer K; Friedrichs N; Patnaik D; Higgins JM; Potier N; Scheidtmann KH; Buettner R; Schüle R
    Nat Cell Biol; 2008 Jan; 10(1):53-60. PubMed ID: 18066052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
    Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
    Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
    Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
    Metzger E; Wissmann M; Yin N; Müller JM; Schneider R; Peters AH; Günther T; Buettner R; Schüle R
    Nature; 2005 Sep; 437(7057):436-9. PubMed ID: 16079795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KAT8 Regulates Androgen Signaling in Prostate Cancer Cells.
    Kim JY; Yu J; Abdulkadir SA; Chakravarti D
    Mol Endocrinol; 2016 Aug; 30(8):925-36. PubMed ID: 27268279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.
    Kim JY; Banerjee T; Vinckevicius A; Luo Q; Parker JB; Baker MR; Radhakrishnan I; Wei JJ; Barish GD; Chakravarti D
    Mol Cell; 2014 May; 54(4):613-25. PubMed ID: 24793694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lestaurtinib inhibits histone phosphorylation and androgen-dependent gene expression in prostate cancer cells.
    Köhler J; Erlenkamp G; Eberlin A; Rumpf T; Slynko I; Metzger E; Schüle R; Sippl W; Jung M
    PLoS One; 2012; 7(4):e34973. PubMed ID: 22532837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: implications for prostate cancer.
    Turner EC; Kavanagh DJ; Mulvaney EP; McLean C; Wikström K; Reid HM; Kinsella BT
    J Biol Chem; 2011 Apr; 286(17):15440-57. PubMed ID: 21357687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer.
    O'Sullivan AG; Mulvaney EP; Hyland PB; Kinsella BT
    Oncotarget; 2015 Sep; 6(28):26437-56. PubMed ID: 26296974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer.
    Metzger E; Müller JM; Ferrari S; Buettner R; Schüle R
    EMBO J; 2003 Jan; 22(2):270-80. PubMed ID: 12514133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells.
    Jilg CA; Ketscher A; Metzger E; Hummel B; Willmann D; Rüsseler V; Drendel V; Imhof A; Jung M; Franz H; Hölz S; Krönig M; Müller JM; Schüle R
    Oncotarget; 2014 Dec; 5(24):12646-64. PubMed ID: 25504435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation.
    Yang S; Zhang J; Zhang Y; Wan X; Zhang C; Huang X; Huang W; Pu H; Pei C; Wu H; Huang Y; Huang S; Li Y
    Prostate; 2015 Jun; 75(9):936-46. PubMed ID: 25728837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II elongation during activation of insulin transcription.
    Francis J; Chakrabarti SK; Garmey JC; Mirmira RG
    J Biol Chem; 2005 Oct; 280(43):36244-53. PubMed ID: 16141209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
    Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
    Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
    Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
    Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
    Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
    Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
    Bu H; Schweiger MR; Manke T; Wunderlich A; Timmermann B; Kerick M; Pasqualini L; Shehu E; Fuchsberger C; Cato AC; Klocker H
    FEBS J; 2013 Mar; 280(5):1249-66. PubMed ID: 23294566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells.
    Jia L; Shen HC; Wantroba M; Khalid O; Liang G; Wang Q; Gentzschein E; Pinski JK; Stanczyk FZ; Jones PA; Coetzee GA
    Mol Cell Biol; 2006 Oct; 26(19):7331-41. PubMed ID: 16980632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure.
    Urbanucci A; Marttila S; Jänne OA; Visakorpi T
    Prostate; 2012 Aug; 72(11):1223-32. PubMed ID: 22212979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.